Cigna Names Brian Evanko CEO as David Cordani Retires
By Colin Kellaher
Cigna Group's longtime leader, David Cordani, is retiring as chief executive of the health insurer later this year and handing the reins to Brian Evanko.
Cigna on Tuesday said Evanko, currently president and chief operating officer, will become CEO of the Bloomfield, Conn., company on July 1, while Cordani will become executive chairman.
Cordani, who joined Cigna in 1991, has been CEO since 2009 and chairman since 2022.
Evanko, 49 years old, joined the company in 1998 and become president and chief operating officer last March.
Cigna said Evanko will receive an annual base salary of $1.3 million as CEO, along with an annual bonus target of $2.6 million, adding that he will join the board on April 1,
Cigna also said Eric Foss, a board member since 2011, will succeed Eric Wiseman as lead independent director on April 1. Wiseman, a director since 2007, will remain on the board.
The company also reaffirmed its 2026 adjusted earnings forecast of at least $30.25 a share.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
March 03, 2026 08:15 ET (13:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States